COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,585 Articles (22,905 medRxiv, 8,680 bioRxiv)

Most recent first Previous |  Page 694: Articles 6931-6940  | Next

Protection against symptomatic disease with the delta and omicron BA.1/BA.2 variants of SARS-CoV-2 after infection and vaccination in adolescents: national observational test-negative case control study, August 2021 to March 2022, England
Powell, A. A., Kirsebom, F., Stowe, J., Lopez-Bernal, J., Ramsay, M., Andrews, N., Ladhani, S. N.
10.1101/2022.08.19.22278987 — Posted: 2022-08-22
Impact of vaccination with SCB-2019 COVID-19 vaccine on transmission of SARS-CoV-2 infection: a household contact study in the Philippines
Tadesse, B. T., Bravo, L., Marks, F., Aziz, A. B., You, Y. A., Sugimoto, J. D., Li, P., Garcia, J., Rockhold, F., Clemens, R.
10.1101/2022.08.18.22278764 — Posted: 2022-08-22
Clinical profile of scrub typhus patients during COVID pandemic: A sub-Himalayan single center experience
Singh, M. B., Bahurupi, Y. A., Panda, P. K., Kalita, D.
10.1101/2022.08.20.22279010 — Posted: 2022-08-22
Clinical Study to Evaluate the Possible Efficacy and Safety of Antibodies Combination (casirivimab and imdevimab) versus standard antiviral therapy as antiviral agent against Corona virus 2 infection in hospitalized COVID-19 patients
Hassan, A. H., Hegazy, S. K., Radwan, S. T.
10.1101/2022.08.20.22279020 — Posted: 2022-08-22
Brain microstructural changes and fatigue after COVID-19
Bispo, D. D. d. C., Brandao, P. R. d. P., Pereira, D. A., Maluf, F. B., Dias, B. A., Paranhos, H. R., Glehn, F. v., Oliveira, A. C. P. d., Regattieri, N. A. T., Silva, L. S., Yasuda, C. L., Soares, A. A. d. S. M., Descoteaux, M.
10.1101/2022.08.20.22279023 — Posted: 2022-08-22
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients
KEMLIN, D., Gemander, N., Depickere, S., Olislagers, V., Georges, D., Waegemans, A., Pannus, P., Lemy, A., Goossens, M. E., Desombere, I., Michiels, J., Vandevenne, M., Heyndrickx, L., Arien, K. K., Matagne, A., Ackerman, M. E., Le Moine, A., Marchant, A.
10.1101/2022.08.21.22279029 — Posted: 2022-08-22
Associations of proton pump inhibitors with susceptibility to pneumonia, influenza, and COVID-19: evidence from a large population based cohort study
Zeng, R., Ma, Y., Zhang, L., Luo, D., Jiang, R., Wu, H., Zhuo, Z., Yang, Q., Li, J., Leung, F., Chen, Q., Sha, W., Hao Chen, H. C.
10.1101/2022.08.21.22279047 — Posted: 2022-08-22
Symptom presentation among SARS-CoV-2 positive cases and the impact of COVID-19 vaccination; three prospective household cohorts
Westerhof, I., de Hoog, M., Ieven, G., Lammens, C., van Beek, J., Rozhnova, G., Eggink, D., Euser, S. M., Wildenbeest, J., van Houten, M., Goossens, H., Giaquinto, C., Bruijning Verhagen, P.
10.1101/2022.08.19.22278985 — Posted: 2022-08-22
Enhancing global preparedness during an ongoing pandemic from partial and noisy data
Klamser, P. P., d'Andrea, V., Di Lauro, F., Zachariae, A., Bontorin, S., di Nardo, A., Hall, M., Maier, B., Ferretti, L., Brockmann, D., De Domenico, M.
10.1101/2022.08.19.22278981 — Posted: 2022-08-22
Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa
Sun, K., Tempia, S., Kleynhans, J., Gottberg, A. v., McMorrow, M. L., Wolter, N., Bhiman, J. N., Moyes, J., Carrim, M., Martinson, N. A., Kahn, K., Lebina, L., du Toit, J. D., Mkhencele, T., Viboud, C., Cohen, C., for the PHIRST group
10.1101/2022.08.19.22278993 — Posted: 2022-08-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).